Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Qiagen ( (QGEN) ).
Qiagen N.V., a company involved in the life sciences industry, has been notified by the Netherlands Authority for the Financial Markets (AFM) about a significant notification concerning its voting rights. The notification, disclosed on the AFM website, involves BlackRock, Inc., which holds a substantial capital interest and voting rights in Qiagen through various subsidiaries. This announcement highlights the influence of BlackRock’s holdings on Qiagen’s shareholder structure and could have implications for the company’s governance and strategic decisions.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,424,740
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.28B
Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue